Serial Number 87346729
Registration 6309155
700

Registration Progress

Application Filed
Feb 23, 2017
Under Examination
Feb 20, 2018
Approved for Publication
Dec 26, 2017
Published for Opposition
Dec 26, 2017
Registered
Mar 30, 2021

Trademark Image

Basic Information

Serial Number
87346729
Registration Number
6309155
Filing Date
February 23, 2017
Registration Date
March 30, 2021
Published for Opposition
December 26, 2017
Drawing Code
2000

Status Summary

Current Status
Active
Status Code
700
Status Date
Mar 30, 2021
Registration
Registered
Classes
009 035 041 042

Rights Holder

Pharmaceutical Research and Manufacturers of America

03
Address
950 F Street, N.W.
Washington, DC 20004

Ownership History

Pharmaceutical Research and Manufacturers of America

Original Applicant
03
Washington, DC

Pharmaceutical Research and Manufacturers of America

Owner at Publication
03
Washington, DC

Pharmaceutical Research and Manufacturers of America

Original Registrant
03
Washington, DC

Legal Representation

Attorney
Margaret A. Esquenet

USPTO Deadlines

Next Deadline
626 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2021-03-30)
Due Date
March 30, 2027
Grace Period Ends
September 30, 2027
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

42 events
Date Code Type Description
Mar 30, 2021 R.PR A REGISTERED-PRINCIPAL REGISTER
Feb 23, 2021 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Feb 22, 2021 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Feb 21, 2021 SUPC I STATEMENT OF USE PROCESSING COMPLETE
Feb 19, 2021 EISU I TEAS STATEMENT OF USE RECEIVED
Feb 19, 2021 IUAF S USE AMENDMENT FILED
Aug 11, 2020 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 9, 2020 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL
Aug 9, 2020 EX5G S SOU EXTENSION 5 GRANTED
Jul 22, 2020 EEXT I SOU TEAS EXTENSION RECEIVED
Jul 22, 2020 EXT5 S SOU EXTENSION 5 FILED
Feb 13, 2020 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 11, 2020 EEXT I SOU TEAS EXTENSION RECEIVED
Feb 11, 2020 EXT4 S SOU EXTENSION 4 FILED
Feb 11, 2020 EX4G S SOU EXTENSION 4 GRANTED
Aug 20, 2019 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 16, 2019 EEXT I SOU TEAS EXTENSION RECEIVED
Aug 16, 2019 EXT3 S SOU EXTENSION 3 FILED
Aug 16, 2019 EX3G S SOU EXTENSION 3 GRANTED
Feb 7, 2019 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 5, 2019 EEXT I SOU TEAS EXTENSION RECEIVED
Feb 5, 2019 EXT2 S SOU EXTENSION 2 FILED
Feb 5, 2019 EX2G S SOU EXTENSION 2 GRANTED
Jul 13, 2018 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 11, 2018 EEXT I SOU TEAS EXTENSION RECEIVED
Jul 11, 2018 EXT1 S SOU EXTENSION 1 FILED
Jul 11, 2018 EX1G S SOU EXTENSION 1 GRANTED
Feb 20, 2018 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Dec 26, 2017 PUBO A PUBLISHED FOR OPPOSITION
Dec 26, 2017 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 6, 2017 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 15, 2017 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 14, 2017 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 13, 2017 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 13, 2017 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
May 23, 2017 CPRA R PRIORITY ACTION WRITTEN
May 23, 2017 GPRA F PRIORITY ACTION E-MAILED
May 23, 2017 GPRN O NOTIFICATION OF PRIORITY ACTION E-MAILED
May 18, 2017 DOCK D ASSIGNED TO EXAMINER
Mar 3, 2017 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED
Mar 2, 2017 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 27, 2017 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 009
Electronic downloadable publications in the nature of fact sheets, reports, and infographics regarding biopharmaceuticals and the biopharmaceutical industry
First Use Anywhere: 20170100
First Use in Commerce: 20170100
Class 035
Association services, namely, promoting the interests of research-based prescription drug manufacturers
First Use Anywhere: 20170100
First Use in Commerce: 20170100
Class 041
Providing a website featuring non-downloadable publications in the nature of testimonials, infographics, fact sheets, reports, articles, and videos regarding biopharmaceuticals and the biopharmaceutical industry
First Use Anywhere: 20170100
First Use in Commerce: 20170100
Class 042
Providing online information regarding medical and scientific research in the field of biopharmaceuticals; providing online information on biopharmaceutical research; providing online information in the field of biopharmaceuticals and biopharmaceutical industry regarding biopharmaceutical safety in the nature of biopharmaceutical testing
First Use Anywhere: 20170100
First Use in Commerce: 20170100

Additional Information

Design Mark
The mark consists of a rectangular pattern formed by three rows of tiles of varying lengths. The tiles in the top row are, from left to right, a forest green rectangle and an apple green rectangle. The tiles in the middle row are, from left to right, a dark green rectangle, a forest green rectangle, and a yellow rectangle. The tiles in the bottom row are, from left to right, an apple green square, a teal rectangle, and a mint green rectangle.
Color Claim
The color(s) forest green, apple green, dark green, yellow, teal and mint green is/are claimed as a feature of the mark.

Classification

International Classes
009 035 041 042